Los Angeles Business Journal

Amgen Denies 'Special Deal' Accusation

Thursday, January 24, 2013

Amgen Inc. is defending a change in Medicare payments included in the recent fiscal-cliff deal which benefits one of its drugs, and is pushing back against a new bill that aims to repeal that change, The Hill and New York Times report.